Prevalence of celiac disease in Germany: A prospective follow-up study

Table 1 Prevalence of celiac disease in different countries

Country	Prevalence	Characteristics of populations studied			Antibody test method
		n	Age (yr) mean/median (range)	Males	tTGA	AGA	EMA
Population-representative samples
Germany (present study)	1:270	2157	42.6 (18-65)	48.03%	-	-	-
New Zealand[1]	1:82	1064	50.2 (> 18)	39.80%		-	-
Iran[2]	1:104	2799	33.7 (18-66)	50%	-		-
Ireland[3]	1:122	1823	NA (15-65)	NA		-	-
Sweden[4]	1:190	1894	50 (25-74)	50%		-	-
Netherlands[5]	1:286	1440	40.6 (20-59)	46%	-		-
Spain[6]	1:390	1170	44.9 (2-89)	44.70%		-	-
Italy[7]	1:559	2237	44 (20-87)	46.90%			-
Greece[8]	1:558	2230	46 (18-80)	45%	-		-
Finland[9]	1:47	2815	NA (52-74)	48%	-
Finland[10]	1:42	4846	NA (30-64)	47%	-		-
Italy[10]	1:145	2759	NA (30-64)	42%	-		-
Germany[10]	1:344	3098	NA (30-64)	49%	-		-
Blood donors
Mexico[11]	1:37	1009	34 (NA)	68%	-
Italy[12]	1:100	1002	33 (13-90)	43.40%	-		-
United States[13]	1:105	2845	NA	43%	-	-	-
Iceland[14]	1:136	813	36 (17-64)	76.30%	-
Brazil[15]	1:214	2045	32.8 (18-61)	87.60%		-	-
Netherlands[16]	1:333	1000	NA	NA			-
Norway[17]	1:340	2069	3 (18-67)	66.30%		-	-
Iran[18]	1:400	2000	35.5 (18-65)	79%		-	-
Brazil[19]	1:681	2045	32.8 (18-61)	87.60%		-	-
Non-population representative collectives
Turkey[20]	1:100	906	38.6 (20-59)	50%	-
Switzerland[21]	1:132	1450	NA (12-18)	39.90%	-		-
Argentina[22]	1:167	2000	29 (16-79)	50%		-	-
Tunisia[23]	1:709	1418	27.5 (17-57)	73%	-		-
England[24]	1:83	7550	59 (45-76)	41%	-		-

tTGA: Tissue transglutaminase antibody; EMA: Endomysial antibody; AGA: Antigliadin antibody; NA: Not available; -: Positive.